![](https://www.businesskorea.co.kr/news/thumbnail/202408/223875_225856_5940_v150.jpg)
Domestic Pharmaceutical and Bio Companies to Accelerate Open Innovation amid 'Leclaza' Success
In a landmark achievement for South Korea's pharmaceutical industry, Yuhan Corporation's lung cancer treatment 'Leclaza' (ingredient name: Lazertinib) has become the first domestically produced anticancer drug to receive approval from the U …